IBBQ

Invesco Nasdaq Biotechnology ETF

NASDAQ Biotechnology TR USD

NAV as of 25-Sep-2023

19.7000

4 Week: 19.72 - 20.84

52 Week: 18.50 - 22.17

Latest Closing Price

19.72

Premium / Discount

0.1

Expense Ratio

0.19%

Investment Objective

The investment seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index ®. The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.

Main Fund Characteristics

Fund Manager:
Invesco
Asset Under Management:
16,597,299
Launch Date:
08/06/2021
Asset Class:
Equity
Replication Method:
Physical-Full
Number of Holdings:
267
Trading Currency:
USD
Style:
Mid Blend
Region/Sector/Strategy:
N.A / Healthcare / N.A
Exchange:
NASDAQ

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-5.980.98-6.10
1 Day0.510.000.00
1 Week-1.641.43-1.15
1 Month-3.273.10-1.06
3 Months-3.136.15-0.51
6 Months-1.749.84-0.18
1 Year8.9618.610.48
2 Years-25.4633.61-0.76
3 Years0.000.000.00
5 Years0.000.000.00
10 Years0.000.000.00

Price History

-

Annual Performance Return

2013201420152016201720182019202020212022
Price (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.0000-10.2395
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 0.00000.00000.00000.00000.00000.00000.00000.00000.000041.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
17/09/202321/09/20230.0412
19/06/202322/06/20230.0453
18/12/202222/12/20220.0419
18/09/202222/09/20220.0377
20/06/202229/06/20220.0426
20/03/202228/04/20220.0378
19/12/202130/12/20210.1051
19/09/202129/09/20210.0432

Portfolio Data

Total Number of Holdings: 267

Number of Bond Holdings: 0

Number of Equity Holdings: 264

Total Market Value: 16,597,299

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Amgen Inc8.72575,40601,447,186

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant6.38
Large35.34
Medium33.78
Small14.00
Micro10.58

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

16.5341

Price/Book*

3.3496

Price/Sales*

4.3549

Price/Cash Flow*

14.3068

Dividend Yield*

0.9376

Growth Measures

Long-Term Earnings

6.5924

Historical Earnings

3.3115

Sales Growth

11.7566

Cash-Flow Growth

7.3481

Book-Value Growth

6.5879

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you